Carlyle Group Inc.
Q3 2023 13F-HR Holdings
Net value change ($000)
-501,724
(-17.9%)
New positions
2
Sold out positions
3
Turnover %
0.3%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SLNO | 62,337 | 1223.7% |
| GETY | 14,413 | 29.6% |
| Vitru Ltd | 9,744 | 9.7% |
| SPWR | 5,142 | NEW |
| SMHI | 3,220 | 21.4% |
| OKUR | 2,861 | 16.2% |
| SPRB | 231 | 3.7% |
| Molecular Templates, Inc. | 84 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| GTM | -334,272 | -35.9% |
| QDEL | -122,359 | -11.9% |
| MKSI | -75,087 | -19.9% |
| VERA | -19,078 | -49.2% |
| PHAT | -13,882 | -27.7% |
| VRNA | -11,870 | -22.9% |
| HilleVax, Inc. | -6,839 | -21.7% |
| JSPR | -5,775 | -48.8% |
| PARATEK PHARMACEUTICALS INC | -2,301 | -100.0% |
| ACET | -2,242 | -43.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|